DOPAMINE (Intropin®)
CLASS:
Catecholamine / Sympathomimetic
Adrenergic Agonist
ACTIONS:
Dose dependent sympathomimetic
At lower drip rates of 1-2 ug/kg/min, stimulate dopaminergic receptors to produce cerebral, renal, and mesenteric vasodilation
At drip rates of 2-10 ug/kg/min, B1 effects predominate (predominantly inotropic effect) with alpha effect beginning (vasoconstriction)
At drip rates 10 -20ug/kg/min, alpha effects predominate with renal, mesenteric, and peripheral arterial, and venous vasoconstriction with marked increase in SVR (systemic vascular resistance)
At drip rates > 20ug/kg/min alpha effects similar to norepinephrine predominate with marked peripheral vasoconstriction and tachycardia
INDICATIONS:
Cardiogenic shock
Other types of shock after adequate fluid resuscitation
Symptomatic bradycardia unresponsive to Atropine or external pacemaker
CONTRAINDICATIONS:
Hypovolemia BEFORE fluid resuscitation
Patients taking monamine oxidase inhibitors
Pheochromocytoma (can precipitate hypertensive crisis) = tumor in the adrenal glands
Uncorrected tachyarrhythmias
STANDARD PREP:
400 mg /250 cc (pre-mixed)
DOSAGE/ROUTE:
See Hawaii S.O. - Bradycardia., Acute Pulmonary Edema. 2.5-20 mcg/kg/min
SIDE EFFECTS:
Tachyarrhythmias
Hypotension
precipitate myocardial ischemia
Tissue necrosis with extravasation (infiltration)
Headache, N/V, angina
Bradycardia
Widening of QRS complex
PRECAUTIONS:
Beta blockers – may decrease the effects of dopamine
Stop infusion if diastolic pressure rises > 90 mm Hg
Incompatible with NaHCO3 since alkaline environment may inactivate dopamine
Avoid extravasation which will cause tissue necrosis and tissue sloughing. Inform ER RN or MD since local injection of Regitine will be required.